Literature DB >> 16961621

Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications.

W C Chapman, H Lockstadt, N Singla, F E Kafie, J H Lawson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16961621     DOI： 10.1111/j.1538-7836.2006.02067.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

Review 1.  Methods to decrease blood loss during liver resection: a network meta-analysis.

Authors:  Elisabetta Moggia; Benjamin Rouse; Constantinos Simillis; Tianjing Li; Jessica Vaughan; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-10-31

Review 2.  Topical hemostatic agents in neurosurgery, a comprehensive review: 15 years update.

Authors:  C Schonauer; C Mastantuoni; T Somma; R de Falco; P Cappabianca; E Tessitore
Journal:  Neurosurg Rev       Date:  2021-11-04       Impact factor: 3.042

Review 3.  Methods to decrease blood loss and transfusion requirements for liver transplantation.

Authors:  Kurinchi Selvan Gurusamy; Theodora Pissanou; Hynek Pikhart; Jessica Vaughan; Andrew K Burroughs; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

4.  Thrombin use in surgery: an evidence-based review of its clinical use.

Authors:  Sung W Ham; Wesley K Lew; Fred A Weaver
Journal:  J Blood Med       Date:  2010-07-22

5.  Clinical use of topical thrombin as a surgical hemostat.

Authors:  Wesley K Lew; Fred A Weaver
Journal:  Biologics       Date:  2008-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.